Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01525810 · ClinicalTrials.gov registry record
Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial
A clinical trial, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 218
- Enrollment target
NCT01525810: Completed study, sponsored by Bristol-Myers Squibb.
NCT01525810 is a clinical trial that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 218 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01525810 has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 218 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine whether the hepatitis C virus continues to remain unable to be detected in subjects who were previously treated with BMS-914143 and achieved sustained virologic response
Primary Outcome
Durability of virologic response as assessed by the time to loss of virologic response in subjects treated in a previous study with BMS-914143 who have HCV RNA less than the limit of quantitation of the assay (\< LOQ) at the completion of the required post-treatment follow-up in the previous study. Loss of virologic response assessed using HCV RNA at 24-week intervals
Interventions
- DRUG Peginterferon Lambda-1a (BMS-914143)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-11 |
What the finished NCT01525810 record still lists
NCT01525810 is an observational study that tracks outcomes without assigning an intervention. The registered 218 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Peginterferon Lambda-1a (BMS-914143) is the first listed.
NCT01525810 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01525810 about?
NCT01525810 is a clinical study titled "Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial". The primary purpose of this study is to determine whether the hepatitis C virus continues to remain unable to be detected in subjects who were previously treated with BMS-914143 and achieved sustained virologic response
What is the current status of trial NCT01525810?
This trial is currently completed. The enrollment target is 218 participants. The study started on 2012-03. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01525810?
The interventions under investigation include: Peginterferon Lambda-1a (BMS-914143) (DRUG).
Who is sponsoring clinical trial NCT01525810?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04693858 · 218 participants · NA
Efficacy Trial of the CALM Intervention
- NCT05909202 · 218 participants · NA
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
- NCT06000761 · 218 participants · NA
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
- NCT06249126 · 218 participants · NA
Primary Subtalar Arthrodesis for Calcaneal Fractures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia